2024 , Vol. 21 >Issue 12: 1111 - 1117
DOI: https://doi.org/10.3877/cma.j.issn.1672-6448.2024.12.003
儿童排泄性尿路超声造影改良方法的初步探讨
Copy editor: 汪荣
收稿日期: 2024-09-30
网络出版日期: 2025-01-23
版权
Improved method of contrast-enhanced voiding urosonography in pediatrics: a preliminary study
Received date: 2024-09-30
Online published: 2025-01-23
Copyright
目的
对儿童排泄性尿路超声造影检查的造影剂用量及方法进行改良,初步探讨其提高造影图像质量的有效性及临床应用价值。
方法
回顾性纳入2019 年1 月至2023 年8 月于复旦大学附属儿科医院超声科完成排泄性尿路超声造影(CeVUS)的患儿137 例。2019 年1 月至2021 年12月采用传统造影方法(单一剂量),2022 年1 月至2023 年8 月采用改良造影方法(依据年龄、膀胱容量等对剂量进行调整)对反流程度进行评估。将注入造影剂后的膀胱显影图像划分为I ~Ⅲ级(I级图像质量最佳,膀胱轮廓完整清晰,膀胱后方受声影遮挡不明显)。比较传统造影方法与改良造影方法膀胱显影图像分级情况。并分析CeVUS 与排泄性逆行尿路造影(VCUG)检查结果的一致性。
结果
137 例中,采用传统CeVUS 检查方法的患儿100 例,采用CeVUS 改良方法检查的患儿37 例。传统方法膀胱显影图像分级:Ⅰ级1 例(1.0%,1/100),Ⅱ级39 例(39.0%,39/100),Ⅲ级60 例(60.0%,60/100);改良方法膀胱显影图像分级:Ⅰ级17 例(45.9%,17/37),Ⅱ级16 例(43.2%,16/37),Ⅲ级4 例(10.8%,4/37)。改良方法得到的图像等级优于传统方法(P<0.01)。共有22 例患儿在CeVUS 相近时间内进行放射科VCUG 检查,两种检查的一致性Kappa 值为0.449(P=0.002)。
结论
CeVUS 改良方法可以使检查过程更为优化,图像更清晰,造影剂使用剂量更小,安全性更好,值得临床推广应用。
刘源鑫 , 何丽莉 , 孙颖华 . 儿童排泄性尿路超声造影改良方法的初步探讨[J]. 中华医学超声杂志(电子版), 2024 , 21(12) : 1111 -1117 . DOI: 10.3877/cma.j.issn.1672-6448.2024.12.003
Objective
To improve contrast-enhanced voiding urosonography (CeVUS) in pediatrics with regard to contrast medium dosage and examination method, and to preliminarily explore its effectiveness and clinical application value in improving the quality of contrast images.
Methods
A retrospective study was performed on 137 children who underwent CeVUS in the Department of Ultrasound of Children's Hospital of Fudan University from January 2019 to August 2023.Traditional contrast method(single dose) was used from January 2019 to December 2021, and improved contrast method (dose adjustment based on age, bladder capacity, etc.) was used from January 2022 to August 2023 to evaluate vesicoureteral reflux.The images of the bladder after injection of contrast agents were divided into levels I ~ III (the image quality of level I is the best, the outline of the bladder is complete and clear, and the back of the bladder is not obviously obscured by shadow).The classification of the developed images was compared between the traditional contrast method and the improved contrast method.The consistency between CeVUS and voiding cystouretrography (VCUG) was analyzed.
Results
Among the 137 cases, 100 were examined by the traditional CeVUS method and 37 by the modified CeVUS method.The classification of bladder images obtained by the traditional method was: 1 case at level I (1.0%, 1/100), 39 cases at level II (39.0%, 39/100),and 60 cases at level III (60.0%, 60/100); for bladder images obtained by the improved method, there were 17 cases at level I (45.9%, 17/37), 16 cases of level II (43.2%, 16/37), and 4 cases of level III (10.8%, 4/37).The image level obtained by the improved method was better than that of the traditional method (P<0.01).A total of 22 children underwent radiology VCUG examination at a similar time to CeVUS, and the Kappa value of the two examinations was 0.449 (P=0.002).
Conclusion
The improved CeVUS method can optimize the examination process, make the image clearer, use less contrast agent dose, and have better safety, which is worthy of clinical application.
表1 CeVUS 改良方法与传统方法的膀胱显影图像分级情况比较[例(%)] |
CeVUS方法 | 例数 | Ⅰ级 | Ⅱ级 | Ⅲ级 |
---|---|---|---|---|
传统方法 | 100 | 1(1.0) | 39(39.0) | 60(60.0) |
改良方法 | 37 | 17(45.9) | 16(43.2) | 4(10.8) |
P值 | <0.001 |
表2 CeVUS 与VCUG 对膀胱输尿管反流的检查结果比较(例) |
CeVUS检查 | VCUG检查 | 总计 | |
---|---|---|---|
发现反流 | 未发现反流 | ||
发现反流 | 19 | 8 | 27 |
未发现反流 | 4 | 13 | 17 |
总计 | 23 | 21 | 44 |
1 |
Hannula A, Venhola M, Renko M, et al.Vesicoureteral reflux in children with suspected and proven urinary tract infection[J].Pediatr Nephrol, 2010, 25(8): 1463-1469.
|
2 |
Printza N, Farmaki E, Piretzi K, et al.Acute phase 99mtcdimercaptosuccinic acid scan in infants with first episode of febrile urinary tract infection[J].World J Pediatr, 2012, 8(1): 52-56.
|
3 |
Chua ME, Kim JK, Mendoza JS, et al.The evaluation of vesicoureteral reflux among children using contrast-enhanced ultrasound: a literature review[J].J Pediatr Urol, 2019, 15(1): 12-17.
|
4 |
Sidhu P, Cantisani V, Deganello A, et al.Role of contrast-enhanced ultrasound (ceus) in paediatric practice: an efsumb position statement[J].Ultraschall Med, 2017, 38(1): 33-43.
|
5 |
张致庆, 沈茜, 何丽莉, 等.儿童膀胱输尿管反流行超声尿路造影病例系列报告[J].中国循证儿科杂志, 2019, 14(5): 380-383.
|
6 |
Bracco.注射用六氟化硫微泡说明书.2021[EB/OL].http://www.bracco.com/zh-cn/product/shengnuowei-sonovuer.
|
7 |
邓劲松, 周路遥, 曾斯慧, 等.Sonovue 排泄性超声尿路造影与x线膀胱尿路造影的比较研究[J].南方医科大学学报, 2013, (10):1467-1470.
|
8 |
杨乐飞, 吴伟, 邹翔宇, 等.超声排泄性尿路造影在膀胱输尿管反流分级中的诊断价值[J].临床儿科杂志, 2021, 39(2): 108-112.
|
9 |
Piscaglia F, Bolondi L.The safety of sonovue in abdominal applications: retrospective analysis of 23188 investigations[J].Ultrasound Med Biol, 2006, 32(9): 1369-1375.
|
10 |
Dietrich CF, Nolsoe CP, Barr RG, et al.Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (ceus) in the liver - update 2020 - wfumb in cooperation with efsumb, afsumb,aium, and flaus[J].Ultraschall Med, 2020, 41(5): 562-585.
|
11 |
Claudon M, Cosgrove D, Albrecht T, et al.Guidelines and good clinical practice recommendations for contrast enhanced ultrasound(ceus) - update 2008[J].Ultraschall Med, 2008, 29(1): 28-44.
|
12 |
Sidhu PS, Cantisani V, Dietrich CF, et al.The efsumb guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (ceus) in non-hepatic applications: update 2017 (long version)[J].Ultraschall Med, 2018, 39(2): e2-e44.
|
13 |
Colleran GC, Barnewolt CE, Chow JS, et al.Intrarenal reflux:diagnosis at contrast-enhanced voiding urosonography[J].J Ultrasound Med, 2016, 35(8): 1811-1819.
|
14 |
张伟, 易惠明, 蔡保欢, 等.排泄性尿路超声造影在儿童膀胱输尿管返流诊断中的应用[J].华中科技大学学报(医学版), 2018,47(1): 105-108.
|
15 |
夏斯莉, 周建敏, 王勤, 等.声学造影诊断小儿膀胱输尿管反流及预测肾脏瘢痕的价值初探[J].中国超声医学杂志, 2022, 38(2):173-176.
|
16 |
Rachmiel M, Aladjem M, Starinsky R, et al.Symptomatic urinary tract infections following voiding cystourethrography[J].Pediatr Nephrol,2005, 20(10): 1449-1452.
|
17 |
Rosado E, Riccabona M.Off-label use of ultrasound contrast agents for intravenous applications in children: analysis of the existing literature[J].J Ultrasound Med, 2016, 35(3): 487-496.
|
18 |
Darge K, Papadopoulou F, Ntoulia A, et al.Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the society for pediatric radiology (spr) and the international contrast ultrasound society (icus)[J].Pediatr Radiol, 2013, 43(9): 1063-1073.
|
19 |
Menichini G, Sessa B, Trinci M, et al.Accuracy of contrast-enhanced ultrasound (ceus) in the identification and characterization of traumatic solid organ lesions in children: a retrospective comparison with baseline us and ce-mdct[J].Radiol Med, 2015, 120(11): 989-1001.
|
20 |
McCarville MB, Kaste SC, Hoffer FA, et al.Contrast-enhanced sonography of malignant pediatric abdominal and pelvic solid tumors:preliminary safety and feasibility data[J].Pediatr Radiol, 2012, 42(7):824-833.
|
21 |
Darge K, Back SJ, Bulas DI, et al.Pediatric contrast-enhanced ultrasound: shedding light on the pursuit of approval in the united states[J].Pediatr Radiol, 2021, 51(12): 2128-2138.
|
22 |
Bracco.Lumason prescribing information.2016 [EB/OL].http://imaging.bracco.com/sites/braccoimaging.com/files/technica_sheet_pdf/US-20160330-LUMASON-PI_0.pdf.
|
23 |
Food & Drug Administration.March 2016 - approved drug product list.2016 [EB/OL].http://www.fda.gov/downloads/drugs/developmentapprovalprocess/ucm071120.pdf.
|
24 |
Darge K, Moeller RT, Trusen A, et al.Diagnosis of vesicoureteric reflux with low-dose contrast-enhanced harmonic ultrasound imaging[J].Pediatr Radiol, 2005, 35(1): 73-78.
|
25 |
Piskunowicz M, Swieton D, Rybczynska D, et al.Comparison of voiding cystourethrography and urosonography with secondgeneration contrast agents in simultaneous prospective study[J].J Ultrason, 2016, 16(67): 339-347.
|
/
〈 |
|
〉 |